Digital twin of cells for drug discovery

Cells are the most advanced piece of engineering on earth resulting from trillions of chemical interactions. However, small perturbations within those interactions, due to mutations or external influences, can lead cells to pathological states, then causing diseases.

For decades, biologists have struggled to identify those causes by iteratively reconstructing cell mechanisms.

At DeepLife, we develop novel approaches based on state-of the art multi-omics data, machine learning, and systems engineering to identify molecular triggers driving back a cell in its healthy state.